The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

James Bell 'did not want to leave his cell because he felt under threat' ...

The U.S. Food and Drug Administration (FDA) has officially dropped its warning letter and enforcement complaint against Whoop ...

Thousands of people lost coverage over as little as $8 in delinquent payments. They didn't know their zero-dollar premiums ...

Out-of-state visitors to the O.C. cities with the highest concentration of addiction treatment centers were 159% more likely ...

The 'Viva La Bam' and 'Jackass' alum, now sober, looks back on the moments of revelation that led to him making major changes ...

GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...

An attorney representing plaintiffs in a whistleblower complaint against Heritage Valley Health System in Sewickley said ...

A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...

Sanofi SNY announced that the phase III Baby-COMET study evaluating Nexviazyme (avalglucosidase alfa) in patients with ...

Several drugs have been widely touted of late for promoting weight loss and lowering high blood sugar. Those available in the U.S.—specifically for obesity—are semaglutide (Wegovy), a once-weekly ...

When a reporter asked Los Angeles mayoral candidate Spencer Pratt about his plans to tackle homelessness, Pratt had a brusque response: “They’re not homeless. They’re drug addicts.” “They are choosing ...